These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 2125362)

  • 1. Enhancement of complement activation and cytolysis of human IgG3 by deletion of hinge exons.
    Michaelsen TE; Aase A; Westby C; Sandlie I
    Scand J Immunol; 1990 Nov; 32(5):517-28. PubMed ID: 2125362
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation of complement by an IgG molecule without a genetic hinge.
    Brekke OH; Michaelsen TE; Sandin R; Sandlie I
    Nature; 1993 Jun; 363(6430):628-30. PubMed ID: 8510754
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibody dependent cell-mediated cytotoxicity induced by chimeric mouse-human IgG subclasses and IgG3 antibodies with altered hinge region.
    Michaelsen TE; Aase A; Norderhaug L; Sandlie I
    Mol Immunol; 1992 Mar; 29(3):319-26. PubMed ID: 1557042
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chimeric mouse human IgG3 antibodies with an IgG4-like hinge region induce complement-mediated lysis more efficiently than IgG3 with normal hinge.
    Norderhaug L; Brekke OH; Bremnes B; Sandin R; Aase A; Michaelsen TE; Sandlie I
    Eur J Immunol; 1991 Oct; 21(10):2379-84. PubMed ID: 1915551
    [TBL] [Abstract][Full Text] [Related]  

  • 5. C1q binding to chimeric monoclonal IgG3 antibodies consisting of mouse variable regions and human constant regions with shortened hinge containing 15 to 47 amino acids.
    Sandlie I; Aase A; Westby C; Michaelsen TE
    Eur J Immunol; 1989 Sep; 19(9):1599-603. PubMed ID: 2792180
    [TBL] [Abstract][Full Text] [Related]  

  • 6. One disulfide bond in front of the second heavy chain constant region is necessary and sufficient for effector functions of human IgG3 without a genetic hinge.
    Michaelsen TE; Brekke OH; Aase A; Sandin RH; Bremnes B; Sandlie I
    Proc Natl Acad Sci U S A; 1994 Sep; 91(20):9243-7. PubMed ID: 7937748
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural difference in the complement activation site of human IgG1 and IgG3.
    Michaelsen TE; Sandlie I; Bratlie DB; Sandin RH; Ihle O
    Scand J Immunol; 2009 Dec; 70(6):553-64. PubMed ID: 19906198
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human IgG1, IgG3, and IgG3 Hinge-Truncated Mutants Show Different Protection Capabilities against Meningococci Depending on the Target Antigen and Epitope Specificity.
    Giuntini S; Granoff DM; Beernink PT; Ihle O; Bratlie D; Michaelsen TE
    Clin Vaccine Immunol; 2016 Aug; 23(8):698-706. PubMed ID: 27307451
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The IGHG3 gene shows a structural polymorphism characterized by different hinge lengths: sequence of a new 2-exon hinge gene.
    Dard P; Huck S; Frippiat JP; Lefranc G; Langaney A; Lefranc MP; Sanchez-Mazas A
    Hum Genet; 1997 Jan; 99(1):138-41. PubMed ID: 9003512
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human IgG3 can adopt the disulfide bond pattern characteristic for IgG1 without resembling it in complement mediated cell lysis.
    Brekke OH; Bremnes B; Sandin R; Aase A; Michaelsen TE; Sandlie I
    Mol Immunol; 1993 Nov; 30(16):1419-25. PubMed ID: 8232327
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Solution conformation of wild-type and mutant IgG3 and IgG4 immunoglobulins using crystallohydrodynamics: possible implications for complement activation.
    Lu Y; Harding SE; Michaelsen TE; Longman E; Davis KG; Ortega A; Grossmann JG; Sandlie I; García de la Torre J
    Biophys J; 2007 Dec; 93(11):3733-44. PubMed ID: 17704171
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of complement by human IgG1 and human IgG3 antibodies against the human leucocyte antigen CD52.
    Redpath S; Michaelsen T; Sandlie I; Clark MR
    Immunology; 1998 Apr; 93(4):595-600. PubMed ID: 9659234
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The structural requirements for complement activation by IgG: does it hinge on the hinge?
    Brekke OH; Michaelsen TE; Sandlie I
    Immunol Today; 1995 Feb; 16(2):85-90. PubMed ID: 7888072
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A mutant human IgG molecule with only one C1q binding site can activate complement and induce lysis of target cells.
    Michaelsen TE; Thommesen JE; Ihle O; Gregers TF; Sandin RH; Brekke OH; Sandlie I
    Eur J Immunol; 2006 Jan; 36(1):129-38. PubMed ID: 16323243
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The extended hinge region of IgG3 is not required for high phagocytic capacity mediated by Fc gamma receptors, but the heavy chains must be disulfide bonded.
    Aase A; Sandlie I; Norderhaug L; Brekke OH; Michaelsen TE
    Eur J Immunol; 1993 Jul; 23(7):1546-51. PubMed ID: 8325331
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of the hinge region on complement activation, C1q binding, and segmental flexibility in chimeric human immunoglobulins.
    Tan LK; Shopes RJ; Oi VT; Morrison SL
    Proc Natl Acad Sci U S A; 1990 Jan; 87(1):162-6. PubMed ID: 2296577
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Different glycosylation pattern of human IgG1 and IgG3 antibodies isolated from transiently as well as permanently transfected cell lines.
    Vestrheim AC; Moen A; Egge-Jacobsen W; Bratlie DB; Michaelsen TE
    Scand J Immunol; 2013 May; 77(5):419-28. PubMed ID: 23488770
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A gamma 3 hinge region probe: first specific human immunoglobulin subclass probe.
    Huck S; Keyeux G; Ghanem N; Lefranc MP; Lefranc G
    FEBS Lett; 1986 Nov; 208(2):221-30. PubMed ID: 2877902
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Segmental flexibility and complement fixation of genetically engineered chimeric human, rabbit and mouse antibodies.
    Dangl JL; Wensel TG; Morrison SL; Stryer L; Herzenberg LA; Oi VT
    EMBO J; 1988 Jul; 7(7):1989-94. PubMed ID: 3138110
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Baboon immunoglobulin constant region heavy chains: identification of four IGHG genes.
    Attanasio R; Jayashankar L; Engleman CN; Scinicariello F
    Immunogenetics; 2002 Nov; 54(8):556-61. PubMed ID: 12439618
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.